Publications by authors named "Luc Larrivee"
Article Synopsis
- Tdap boosters are not currently recommended for adults in Canada and the U.S., even though regular tetanus and diphtheria boosters are.
- An open-label study involving 769 adults compared the safety and immune response of a first dose of Tdap with a repeat dose for those who had received it 10 years earlier.
- Results showed that both groups had high rates of mild adverse events post-vaccination, with antibody levels reaching noninferiority benchmarks for tetanus and diphtheria, while the repeat dose group showed slightly better pertussis immunity, indicating good safety and immune response for the repeat Tdap dose.
